Corbion NV

Corbion NV

24.80
EUR
+0.54
(+2.23%)
1.16BMarket Cap
Feb 26Next Earn
Corbion NV
TG:CSUA
(Tradegate Exchange)

Recent

price

24.80

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
EUR
44.3
10.23
10.48
10.55
12.46
15.2
15.6
15.35
15.28
16.61
16.75
18.18
24.71
21.4
22.05
21.86
- -
Revenue per Share
1.47
-2.56
-0.96
-0.01
-0.33
1.29
1.74
1.46
0.93
0.44
1.24
1.33
1.53
1.23
3.29
1.29
- -
Basic EPS, GAAP
1.7
0.76
2.01
-0.8
-0.02
0.83
1.15
2.03
1.7
1.95
1.85
0.38
0.66
2.8
3.15
2.77
- -
Free Cash Flow per Basic Share
0.54
0.33
0.3
0.99
0.09
0.97
0.9
1.04
0.56
0.56
0.56
0.56
0.56
0.56
0.72
0.64
- -
Dividend per Share
16.96
13.6
11.35
7.02
8.26
8.21
8.69
8.35
8.85
9
8.76
9.4
10.6
10.77
13.29
12.89
13.11
Book Value per Share
-0.45
0.1
10.02
5.66
6.27
5.88
6.28
6.12
6.48
6.06
5.95
6.72
7.83
8.12
11.59
11.34
11.6
Tangible Book Value per Share
68
70
72
71
62
60
58
58
59
59
59
59
59
59
58
58
58
Basic Weighted Avg Shares
2,990
714
754
744
770
918
911
892
897
976
987
1,071
1,458
1,264
1,288
1,267
- -
Sales/Revenue/Turnover
5.29
6.96
4.99
5.04
1.68
11.83
13.93
13.72
9.8
6.28
9.12
4.39
7.11
6.53
5.94
9.19
- -
Operating Margin (%)
107
37
43
41
44
46
50
45
42
62
60
64
76
85
87
86
- -
Depreciation Expense
99
-174
-65
2
-18
80
104
85
54
26
73
78
90
73
192
75
- -
Net Income, GAAP
23.91
- -
- -
72.92
1,063.16
21.53
12.13
13.41
22.21
42.28
16.65
9.48
22.68
5.07
26.56
21.18
- -
Effective Tax Rate (%)
3.32
-24.4
-8.66
0.3
-2.38
8.73
11.37
9.49
6.05
2.64
7.41
7.31
6.17
5.77
14.92
5.9
- -
Profit Margin (%)
324
350
1,021
186
132
197
200
133
90
25
151
184
62
-9
75
273
289
Working Capital
- -
727
604
94
36
154
133
117
134
169
284
419
437
417
308
348
361
LT Debt
1,117
919
794
505
509
488
499
489
520
529
516
554
626
636
773
743
756
Total Equity
9.73
- -
- -
1.01
-20.34
12.86
16.31
15.84
9.44
4.26
9.92
7.7
6.97
5.18
4.15
7.34
- -
Return on Invested Capital (%)
8.91
- -
- -
0.58
-10.95
12.96
16.25
13.82
8.89
4.12
9.77
9.5
8.45
7.2
15.43
7.07
- -
Return on Capital (%)
9.39
-17.54
-8.06
-0.09
-4.08
15.65
20.58
17.13
10.76
4.92
13.99
14.63
15.26
11.55
27.29
9.87
- -
Return on Common Equity (%)

Capital Structure

EUR

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
99
- -
156
LT Borrowings
313
- -
320
LT Finance Leases
35
- -
41
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
58
58
58
Market Capitalization
1,056
1,098
1,162

Working Capital

EUR

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
580
- -
635
Cash, Cash Equivalents & STI
45
- -
36
Accounts Receivable, Net
175
- -
218
Inventories
241
- -
253
Total Current Liabilities
307
- -
346
Payables & Accruals
- -
- -
- -
ST Debt
99
- -
156
Deferred Revenue
- -
- -
- -

Growth Rates

EUR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
4.54%
7.91%
-3.87%
Free Cash Flow
42.13%
63.49%
-12.6%
Net Income, GAAP
21.15%
21.12%
-61.08%
Sales/Revenue/Turnover
3.93%
6.34%
-1.61%
Total Cash Common Dividend
- -
- -
-11.22%

Quarterly Revenue

EUR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
1,288
2025
- -
- -
- -
- -
1,267
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

EUR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
3.29
2025
- -
- -
- -
- -
1.29
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

EUR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.72
2025
- -
- -
- -
- -
0.64
2026
- -
- -
- -
- -
- -
Business
Corbion N.V. is a Netherlands-based sustainable ingredients company specializing in the development, production, and sale of biobased ingredients and solutions across food, health, and material sectors. The company operates primarily through two business units: Functional Ingredients & Solutions and Health & Nutrition. Its core product portfolio includes lactic acid and lactic acid derivatives; biochemicals such as gluconic acid; food preservation solutions; functional blends; bakery ingredients including bread improvers and egg replacers; algae-based ingredients like AlgaPrime DHA for pet nutrition; and bioplastics, notably PLA (polylactic acid) polymers produced through its 50/50 joint venture with TotalEnergies. Corbion serves diverse markets including food and beverage, animal nutrition, pharmaceuticals, personal care, medical devices, electronics, and biodegradable materials. The company maintains global operations with production sites in the United States, Brazil, Mexico, Spain, the Netherlands, and Thailand, supported by an international sales network. Founded in 1919, Corbion is headquartered in Amsterdam and listed on Euronext Amsterdam. In the last two years, Corbion undertook a strategic restructuring announced in January 2024, consolidating its three prior business units into the current two to enhance operational efficiency. This restructuring included the divestiture of its non-core emulsifiers business through a sale to Kingswood Capital Management for $362 million. Corbion has launched innovative bakery solutions such as its Vantage 12E and 11E egg replacers to address fluctuating egg market conditions and support product consistency for manufacturers. With a focus on sustainability, Corbion continues to expand its bioplastics segment via Luminy PLA production and actively develops its Health & Nutrition segment with new launches in food ferments and high-potency vinegars. The company also announced a share buyback program in 2024 for up to €20 million to enhance shareholder value. Corbion leverages its advanced fermentation and preservation technologies to meet growing demand for sustainable, functional ingredients globally. Corbion’s business strategy centers on sustainable growth through innovation in bio-based ingredients and materials aligned with global market trends toward health, nutrition, and environmental responsibility. Its customer base spans food manufacturers, retailers, pharmaceutical companies, personal care producers, and industrial partners in bioplastics. The company employs approximately 2,400 people worldwide and is positioned as a leader in lactic acid production and applications, underpinning its role in the bioeconomy and circular economy sectors. Through partnerships such as the joint venture with TotalEnergies and acquisitions to bolster its algae ingredients portfolio, Corbion continues to strengthen its technological and market position in the sustainable ingredients industry.

Company News

  • Corbion N.V. (CSNVY) Q2 2026 Earnings Call Transcript

  • Corbion N.V. (CSNVY) Q1 2026 Earnings Call Transcript

  • Corbion N.V. (CSNVY) Q4 2025 Earnings Call Transcript

  • Corbion N.V. (CSNVY) Analyst/Investor Day Transcript

  • Corbion reports the progress of its share buyback program 6 October – 10 October 2025

  • Corbion reports the progress of its share buyback program 29 September – 3 October 2025

  • Corbion joins the Ferment4Health Project to unlock the gut health potential of fermented foods

  • Corbion General Shareholders Meeting approves Board (re)appointments and dividend

  • Corbion N.V. (CSNVF) Q4 2024 Earnings Call Transcript